Abstract
Non-structural 5A (NS5A) protein plays a crucial role in the replication of hepatitis C virus (HCV) and during the past decade has attracted increasing attention as a promising biological target for the treatment of viral infections and related disorders. Small-molecule NS5A inhibitors have shown significant antiviral activity in vitro and in vivo. Several lead molecules are reasonably regarded as novel highly potent drug candidates with favorable ADME features and tolerable side effects. The first-in-class daclatasvir has recently been launched into the market and 14 novel molecules are currently under evaluation in clinical trials. From this perspective, we provide an overview of the available chemical space of small-molecule NS5A inhibitors and their PK properties, mainly focusing on the diversity in structure and scaffold representation.
Keywords: NS5A, Inhibitors, Antiviral, HCV, ADME, Pharmacokinetics.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors
Volume: 16 Issue: 12
Author(s): Yan A. Ivanenkov, Mark S. Veselov, Artem G. Shakhbazyan, Vladimir A. Aladinskiy, Anastasia V. Aladinskaya, Sofya M. Yartseva, Alexander G. Majouga, Anton S. Vantskul, Sergey V. Leonov, Alexandre V. Ivachtchenko and Victor E. Koteliansky
Affiliation:
Keywords: NS5A, Inhibitors, Antiviral, HCV, ADME, Pharmacokinetics.
Abstract: Non-structural 5A (NS5A) protein plays a crucial role in the replication of hepatitis C virus (HCV) and during the past decade has attracted increasing attention as a promising biological target for the treatment of viral infections and related disorders. Small-molecule NS5A inhibitors have shown significant antiviral activity in vitro and in vivo. Several lead molecules are reasonably regarded as novel highly potent drug candidates with favorable ADME features and tolerable side effects. The first-in-class daclatasvir has recently been launched into the market and 14 novel molecules are currently under evaluation in clinical trials. From this perspective, we provide an overview of the available chemical space of small-molecule NS5A inhibitors and their PK properties, mainly focusing on the diversity in structure and scaffold representation.
Export Options
About this article
Cite this article as:
Ivanenkov A. Yan, Veselov S. Mark, Shakhbazyan G. Artem, Aladinskiy A. Vladimir, Aladinskaya V. Anastasia, Yartseva M. Sofya, Majouga G. Alexander, Vantskul S. Anton, Leonov V. Sergey, Ivachtchenko V. Alexandre and Koteliansky E. Victor, A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors, Current Topics in Medicinal Chemistry 2016; 16 (12) . https://dx.doi.org/10.2174/1568026616666151120113040
DOI https://dx.doi.org/10.2174/1568026616666151120113040 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics Significance of Various Experimental Models and Assay Techniques in Cancer Diagnosis
Mini-Reviews in Medicinal Chemistry Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment
MicroRNA Recent Advances in the Therapeutic Perspectives of Nutlin-3
Current Pharmaceutical Design Review on Documented Medicinal Plants used for the Treatment of Cancer
Current Traditional Medicine Progress Toward Vector Design for Hematopoietic Stem Cell Gene Therapy
Current Gene Therapy Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase
Current Medicinal Chemistry Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Current Gene Therapy Epigenetic Regulators Governing Cancer Stem Cells and Epithelial- Mesenchymal Transition in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy Chemotherapy of Chagas Disease
Current Pharmaceutical Design Production of Lentivectors for Clinical Use
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Base Excision Repair, the Redox Environment and Therapeutic Implications
Current Molecular Pharmacology Seeking the 5th Base of DNA Using Chromatographic Methods of Analysis
Current Organic Chemistry VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design Formulation Optimization of Etoposide Loaded PLGA Nanoparticles by Double Factorial Design and their Evaluation
Current Drug Delivery Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery Diversity of Anticancer and Antimicrobial Compounds from Lichens and Lichen-derived Fungi: A Systematic Review (1985-2017)
Current Organic Chemistry Stem Cell Defects in Philadelphia Chromosome Negative Chronic Myeloproliferative Disorders: A Phenotypic and Molecular Puzzle?
Current Stem Cell Research & Therapy